Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINIT: Intranasal Insulin for Primary Prevention of Type 1 Diabetes
NCT03182322Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- May 2018
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in type 1 diabetes mellitus (T1D), sponsored by Technical University of Munich. Started May 2018; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03182322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182322.